If G-PDC and other neurological disorders converge on the dysregulation of proteostasis as a common underlying mechanism of pathogenesis, exploring PQC pathways to restore proteostasis could be a promising strategy to find therapies for multiple neurodegenerative diseases. This evidence concerns the gene GPD1 and neurodegenerative disease.